首页> 外文期刊>Pharmaceutical research >Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
【24h】

Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.

机译:辛伐他汀(一种低tg药物)的喷雾干燥无定形固体分散体:体内和体外评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To obtain free flowing, stable, amorphous solid dispersions (SDs) of simvastatin (SIM), a drug with relatively lower glass transition temperature (T(g)) by spray drying technique, and to perform comparative in vivo study in rats, which could justify the improvement in rate and extent of in vitro drug release. METHODS: Dichloromethane suspensions of SIM either alone or in combination with PVP (1:1 or 1:2 parts by weight) were spray dried with proposed quantity of Aerosil 200 (1:1, 1:1:1, 1:2:2 parts by weight of SIM, Aerosil 200 and PVP, respectively). SDs were characterized initially in comparison with pure drug and corresponding physical mixtures in same ratios by drug content, saturation solubility, SEM, DSC, XRPD, IR, and in vitro drug release. SD 1:2:2 was further subjected to accelerated stability testing and checked for in vitro drug release and presence of crystallinity using DSC and XRPD. In addition, improvement in rate and extent of in vitro drug release from SD 1:2:2 was justified by in vivo study in rats. RESULTS: Combination of SD and surface adsorption techniques has been attempted to overcome the limitations of spray drying technique for amorphization of low T(g) drugs. Based on powder characteristics, drug content, saturation solubility, and feasibility of processing into tablets; SD 1:2:2 was selected as the optimized formulation. During initial characterization, SEM, DSC, and XRPD analyses confirmed the presence of amorphous form in SD 1:2:2. IR spectroscopy revealed possibility of hydrogen bonding interaction between SIM and PVP in SDs. Also, there was dramatical improvement in rate and extent of in vitro drug release of SD 1:2:2. Insignificant decrease in dissolution was observed with no evidence of crystallinity during accelerated stability studies of SD 1:2:2. Moreover in vivo study in rats also justified the improvement in therapeutic efficacy of SD 1:2:2 over pure SIM. CONCLUSIONS: Thus, present study demonstrates high potential of spray drying technique for obtaining stable amorphous SDs of low T(g) drugs.
机译:目的:通过喷雾干燥技术获得玻璃化转变温度(T(g))相对较低的辛伐他汀(SIM)的自由流动,稳定,无定形固体分散体(SD),并在大鼠中进行比较体内研究,这可以证明体外药物释放速率和程度的改善。方法:将SIM的二氯甲烷悬浮液(单独或与PVP组合(1:1或1:2重量份))用建议量的Aerosil 200(1:1、1:1:1、1:2:2)喷雾干燥分别为SIM,Aerosil 200和PVP的重量份)。与纯药物和相同比例的相应物理混合物相比,SD的最初特征是药物含量,饱和溶解度,SEM,DSC,XRPD,IR和体外药物释放。将SD 1:2:2进一步进行加速稳定性测试,并使用DSC和XRPD检查体外药物释放和结晶度。另外,通过大鼠体内研究证明了从SD 1:2:2释放体外药物的速率和程度的改善是合理的。结果:已尝试将SD和表面吸附技术相结合,以克服喷雾干燥技术对低T(g)药物非晶化的限制。基于粉末特性,药物含量,饱和溶解度以及加工成片剂的可行性;选择SD 1:2:2作为优化配方。在初始表征期间,SEM,DSC和XRPD分析确认了SD 1:2:2中存在无定形形式。红外光谱揭示了SD中SIM和PVP之间氢键相互作用的可能性。同样,SD 1:2:2的体外药物释放速率和程度也有了显着改善。在SD 1:2:2的加速稳定性研究过程中,观察到溶出度降低不明显,没有结晶性证据。此外,在大鼠中进行的体内研究也证明了SD 1:2:2的治疗效果优于纯SIM的治疗效果。结论:因此,本研究证明喷雾干燥技术具有获得低T(g)药物的稳定无定形SD的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号